Use of second-line and beyond maintenance therapies in adult patients with primary immune thrombocytopenia in Europe: a parallel study of six prospective multicenter national registries.

IF 8.2 1区医学 Q1 HEMATOLOGY

Haematologica Pub Date : 2025-06-26 DOI:10.3324/haematol.2025.287408

Guillaume Moulis,Frederick Chen,Giuseppe Carli,Waleed Ghanima,Karolin Trautmann-Grill,Thomas Stauch,Alexandra Schifferli,Haroon Miah,Manuela Rueter,Lisanna Ghiotto,Riccardo Tomasello,Annabell Georgi,Vickie McDonald,Francesco Zaja,Heidi Hassel Pettersen,Thomas Kühne,Maria Luisa Lozano,Tomás José González-López,Drew Provan,Marc Michel,Nichola Cooper,Francesco Rodeghiero

引用次数: 0

Abstract

Not available.

查看原文本刊更多论文

欧洲原发性免疫性血小板减少症成年患者使用二线及以上维持治疗：6个前瞻性多中心国家登记处的平行研究

不可用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.